On August 28, the Federal Circuit ruled in favor of Finnegan client NOVA Chemical Corp., finding Dow Chemical Co.’s patent claims to be invalid for indefiniteness in light of the Supreme Court’s Nautilus decision. The ruling also reversed an award of supplemental damages in excess of $30 million.
NOVA Chemicals Corp., United States Court of Appeals for the Federal Circuit (CAFC), Nautilus Inc. v. Biosig Instrument Inc., indefiniteness (35 USC § 112)
Commentary
April 11, 2024
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.